This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Drugs prescribed according to NYHA class

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The use of major classes of drugs in the control of HF according to NYHA class is as follows:

  • NYHA I - ACE inhibitor, beta blocker
  • NYHA II-III - ACE inhibitor, beta blocker, candesartan (intiation requires specialist advice)
  • NYHA III-IV - ACE inhibitor, beta blocker, spironolactone (intiation requires specialist advice)

Combination of an ACE inhibitor, an angiotensin receptor blocker and spirnolactone is not recommended since the safety and efficacy of combining these drugs is uncertain (1).

Reference:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.